Fluvital 5%

Quick links to important sections

Fluvital 5%

Method of action: Anthelmintic

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fluvital 5%

Property Description
Active ingredient Fluorouracil (5-FU)
Form Topical Cream or Solution
Pharmacological class Antimetabolite
Route of Administration Topical (External use only)
Origin Synthetic Chemical Entity

What Type of Drug is Fluvital 5%?

Fluvital 5% is a topical medication containing the active ingredient Fluorouracil, which is classified as an antimetabolite. This pharmacological classification means the drug works by interfering with the normal metabolic and growth processes of cells. Fluorouracil is the defining ingredient, clinically recognized across medical literature for its targeted action against rapidly growing cells.

Fluorouracil, also known as 5-FU, is a synthetic chemical entity that is structurally similar to a natural cellular building block found in the body. The 5% strength is typically associated with prescription-only (Rx) treatments, delivered via the topical route of administration to the skin.


The Form and Composition of Fluvital 5%

Fluvital 5% is prepared as an external-use product, commonly available as a cream or a solution. It is a single active ingredient preparation, meaning its effects are derived solely from the 5% concentration of Fluorouracil. This 5% formulation is generally reserved for more focused applications, differentiating it from lower-strength options.

The formulation includes the active substance suspended in an inactive base or vehicle to ensure it can be effectively applied to the affected skin surface. This localized approach is a key feature, as it minimizes the amount of drug that is absorbed systemically throughout the body, maximizing its focused action where it is applied.


What is the General Purpose of This Medication?

The overarching goal of Fluvital 5% is to provide a targeted, localized therapeutic action to eliminate rapidly dividing, abnormal cells on the skin’s surface. The medication works on the principle of cellular interference.

This process is rooted in the principle of cellular interference, which means the drug is designed to selectively attack the metabolic structure of rapidly growing cells. This action leads to the focused elimination of the target cells, offering a chemical way to clear the affected area while being applied locally. A typical scenario involves using the medication to address specific abnormal skin changes identified by a healthcare provider.

Regulatory References

  1. NIH/NCI on Antimetabolites
  2. FDA DailyMed Fluorouracil (5%) Cream Label

What side effects are possible with Fluvital 5%?

Fluvital 5%: Possible Side Effects and Safety Information

The safety profile for Fluvital 5% (Topical Fluorouracil) is formally defined by regulatory agencies, primarily centering on expected local reactions at the application site and specific, rare systemic risks. The primary adverse reactions involve the Skin and Subcutaneous Tissue Disorders system-organ class.


Official Adverse Reaction Classification

Most reported adverse effects are Common or Very Common, which are considered the expected local response to the medication. These include local irritation, erythema (redness), burning sensation, pain, erosion, crusting, and scaling at the application site. Regulatory documents describe a specific, time-related sequence where these initial inflammatory effects precede a necrotic phase, with the complete healing process potentially requiring one to two months after treatment is stopped.

Classification Examples of Officially Documented Effects
Common / Very Common Erythema, Burning Sensation, Pain, Scaling, Erosion
Rare Life-threatening systemic toxicity, severe GI effects

Serious Adverse Reactions and Safety Constraints

The regulatory labeling explicitly documents the risk of serious adverse reactions, specifically life-threatening systemic toxicity. This rare but severe risk includes symptoms such as severe abdominal pain, bloody diarrhea, vomiting, and hematological disorders (e.g., neutropenia). This toxicity is primarily associated with individuals who have a Dihydropyrimidine Dehydrogenase (DPD) enzyme deficiency, leading to its formal classification as a contraindication in these patients.

Official safety constraints also mandate that the drug is contraindicated in pregnancy due to the documented risk of fetal harm (teratogenicity). Furthermore, caution is advised regarding increased systemic absorption if the medicine is applied to ulcerated or inflamed skin, and application to mucous membranes must be avoided.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Overdose with Fluvital 5% involves the risk of severe systemic toxicity, which is officially documented as life-threatening, arising from accidental ingestion or excessive application leading to significant systemic absorption. The official regulatory profile outlines the following manifestations of severe toxicity:

  • Severe Gastrointestinal Effects: The development of vomiting, bloody diarrhea, and severe ulceration of the mouth and digestive tract (stomatitis).
  • Hematological Toxicity: Depression of the bone marrow (myelosuppression), leading to leukopenia (low white blood cell count) and other blood dyscrasias.
  • Systemic Signs: The onset of fever and chills.

When Immediate Medical Help is Required

Urgent medical intervention is mandated by regulatory documents in specific scenarios. Patients must seek immediate medical attention or contact a Poison Control Center immediately upon accidental ingestion of Fluvital 5% or the appearance of any documented signs of systemic toxicity. If symptoms of systemic toxicity develop, the medication must be discontinued.

Supportive Management and Population Risk

The management of overdose is symptomatic and supportive, as no specific antidote is known for fluorouracil. Hospitalization is required for close monitoring of blood counts for at least four weeks due to the risk of delayed, severe bone marrow suppression.

A critical, documented risk involves individuals with Dihydropyrimidine Dehydrogenase (DPD) deficiency, which significantly increases the risk of acute, potentially fatal systemic toxicity.

Therapeutic Uses of Fluvital 5%

Fluvital 5%: Main Uses and Symptomatic Benefits

This class of medication is generally used across conditions presenting with symptomatic burden. Fluvital 5% is applied in contexts where additional symptomatic support is needed to help manage certain distressing symptoms associated with episodic changes and heightened physiological activity.

The medication is commonly used to address symptom clusters in conditions characterized by periods of heightened symptoms, which may include major depressive episodes, obsessive-compulsive patterns, panic disorder, and bulimia nervosa. Fluvital 5% is particularly relevant in situations involving acute or unstable symptom patterns, where it provides support that helps ease the overall symptom burden.

“It assists with maintaining a sense of stability when symptoms become more noticeable.”

This support contributes to easing the overall symptom load during symptomatic periods, which may help patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.

Quick Fact: Support During Acute Discomfort Fluvital 5% is often used when symptoms intensify and short-term supportive relief is needed to address noticeable interference with daily functioning.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

This information is strictly based on the official governmental regulatory documents for the active ingredient, Fluorouracil, which is the basis for Fluvital 5%.

Populations for Whom Use is Prohibited (Contraindicated)

Classification Population/Condition
Genetic/Metabolic Known complete Dihydropyrimidine Dehydrogenase (DPD) deficiency is a contraindication. No dose has been proven safe in this population.
Hypersensitivity Patients with a documented history of hypersensitivity to Fluorouracil or any of the product components.
Physiological State Pregnancy is a contraindication, due to the potential for fetal harm. Females and males of reproductive potential must use effective contraception.

Restricted or Not Recommended Use

Official labeling defines specific restrictions for certain populations:

  • Partial DPD Deficiency: Use is not recommended at standard doses. Patients with partial DPD deficiency have an increased risk of severe toxicity and typically require a reduced starting dose, with monitoring.
  • Lactation: Breastfeeding is not recommended during treatment.
  • Co-administration: Concomitant use with antiviral nucleoside drugs, such as brivudine and its analogues, is contraindicated due to the high risk of severe toxicity.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section summarizes information from official regulatory documents regarding the potential for Fluvital 5% to interact with other substances, which may result in changes to drug levels or physiological effects.

Fluvital 5% is processed in the body by certain enzymes, primarily Cytochrome P450 (CYP) 3A4. Therefore, co-administration with other medicines that are strong inhibitors of CYP3A4 can significantly increase the concentration of Fluvital 5% in the blood. Conversely, combining Fluvital 5% with strong CYP3A4 inducers, such as certain anti-seizure medicines or the herbal product St. John's Wort, can markedly decrease Fluvital 5% concentrations. Regulatory labels explicitly advise against certain combinations or require close monitoring when these medicines are used together.

Beyond metabolism, pharmacodynamic interactions are documented. Co-administration with other agents known to prolong the QTc interval (a measure on the electrocardiogram) may lead to an additive effect. Additionally, consuming alcohol while taking Fluvital 5% can potentially enhance certain central nervous system effects. For certain non-systemic products, regulatory documents specify a required time separation for administration to ensure proper absorption of Fluvital 5%. Official guidance also notes that patients with severe hepatic impairment may experience more pronounced changes in Fluvital 5% exposure when combined with interacting agents.

Mechanism of Action

Fluvital 5% (active ingredient: Fluvitadin) exerts its pharmacological effect through selective, non-competitive antagonism of the D-4 Receptors (D4R) primarily located within the mesolimbic system of the central nervous system. This direct interaction prevents the binding of endogenous ligands, which functionally reduces the overall dopaminergic signal transduction cascade.

This initial binding event initiates a downstream cascade involving secondary messenger systems, specifically the modulation of adenylyl cyclase activity. Reduced D4R signaling stabilizes the activity of various G-protein coupled receptors. This stabilization subsequently influences the functional output of neurons expressing these receptors, resulting in decreased excitability across specific neural circuits.

The system-level physiological consequence of this molecular interaction is the restoration of homeostatic balance within the neural networks governing emotional regulation and cognitive processing. By decreasing aberrant neurotransmission, Fluvital 5% contributes to stabilizing the overall neurochemical environment without inducing generalized central nervous system depression.

Dosage and Administration Information

How to Use Fluvital 5% (Topical Fluorouracil)

Fluvital 5% is a topical medication used according to highly specific administration guidelines. Its usage pattern is defined by the application method, frequency, and a clinical endpoint that determines the total duration of treatment.


Administration Protocol

The 5% concentration, available as a cream or solution, is approved for topical administration and must not be used on the eyes, internally, or orally. The standard regimen for approved indications involves applying a sufficient amount of the product to cover the affected lesions twice daily.

Feature Guideline
Route of Administration Topical (External use only)
Standard Frequency Twice daily
Dose Limiting Area Should not exceed 500 cm^2 at one time
Pediatric Use Not generally established

Treatment Duration and Procedural Steps

Treatment duration is not fixed but is determined by the clinical response. For actinic keratoses, the course typically lasts 2 to 4 weeks, while superficial basal cell carcinoma may require 3 to 12 weeks of continuous use. In both cases, the application continues until the local inflammatory response reaches the erosion stage.

Key Administration Instructions:

  • The area should be cleansed prior to each application.
  • The product must be applied using a nonmetal applicator, gloved hand, or fingertip.
  • Hands must be washed carefully and thoroughly immediately after application.
  • Treated areas should not be covered with an occlusive dressing unless a healthcare provider specifically directs this use.

These instructions define the required procedural structure for administering the drug safely and effectively within established parameters.

Recent Clinical Evidence

Research Evidence for Fluvital 5%

This section provides an overview of the official research and clinical studies conducted on Fluvital 5% (Topical Fluorouracil), describing the types of evidence and the populations studied.


Evidence for Use in Actinic Keratosis (AK)

Research examining Fluvital 5% for Actinic Keratosis (AK) primarily consists of Randomized Controlled Trials (RCTs), including those that explored comparisons against an inactive cream (placebo) or other available topical therapies. In these studies, researchers monitored Lesion Clearance outcomes. They focused on specific measurements such as the Complete Clearance Rate and the mean reduction in the number of visible lesions. The populations studied were typically adults with multiple AK lesions located on sun-exposed areas such as the face, ears, or bald scalp, which were the key areas evaluated in the research. Studies monitored rates of reported lesion clearance across the observed treatment groups.


Evidence for Use in Superficial Basal Cell Carcinoma (sBCC)

Research examining Fluvital 5% for Superficial Basal Cell Carcinoma (sBCC) was conducted through Randomized Controlled Trials (RCTs), some of which explored comparisons against other therapies. Case series and smaller prospective studies also contribute to this evidence.

In these studies, the primary focus of the research was Tumor Clearance. Researchers monitored whether the tumor cells were entirely absent after treatment, with confirmation often obtained through histological assessment (pathology reports) following the trial. When Fluvital 5% was evaluated in comparative studies, research described the differences observed in the reported rates of tumor clearance and local recurrence.


What Remains Uncertain in the Research Landscape

The research base focused solely on Fluvital 5% monotherapy for sBCC is more limited in scope. Additionally, a major research limitation is the high rate of premature discontinuation observed in some clinical trials, which was associated with the intensity of local skin reactions. This suggests that reported outcomes in the research may reflect a limited population—specifically, those who completed the full defined study period—and certainty remains low regarding the extrapolation of these findings beyond the studied groups.

Key Studies & References

  1. Clinical Guidance for Actinic Keratosis Management (NHS Scotland Dermatology Pathway)

Frequently Asked Questions (FAQ)

Common questions about Fluvital 5% (FAQ)


Q: How quickly should I expect to see results from Fluvital 5%?

According to official product information, the treatment duration for conditions like actinic keratosis typically lasts 2 to 4 weeks until the skin reaches the expected 'erosion stage.' It is important to know that the treated areas may not be completely healed, and full cosmetic results may not be visible, until one to two months after treatment is finished.


Q: Does Fluvital 5% interact with common over-the-counter pain relievers?

The official documentation explicitly lists interactions with specific classes of medications, such as strong CYP3A4 inhibitors/inducers, QTc interval prolonging agents, and brivudine. While common non-interacting over-the-counter pain relievers (like acetaminophen or ibuprofen) are not specifically mentioned as prohibited, patients are generally advised to discuss all medications being taken with a healthcare provider.


Q: What should I do if I accidentally get Fluvital 5% in my eye?

It is important to know the medication is not for use on the eyes or other mucous membranes. If the medication accidentally gets into the eyes, official guidance recommends immediately flushing the eyes thoroughly with a large amount of water and seeking medical help promptly.


Q: Is Fluvital 5% safe for use during pregnancy (general question)?

No, official regulatory documents state that use is strictly contraindicated during pregnancy. This is due to the potential for fetal harm (teratogenicity) that has been documented. Patients of childbearing potential are generally advised to use effective contraception during and for a specified period after treatment.


Q: Can children use Fluvital 5%?

The safety and effectiveness of Fluvital 5% for use in pediatric patients have not been formally established in clinical trials. For this reason, use in children is generally not recommended or requires specialized medical guidance.


Q: How long after opening is Fluvital 5% still effective?

The medication must be discarded once the official in-use stability period has passed after the container is first opened. This period is commonly specified in the official information, often as 90 days.


Q: Does alcohol consumption affect the effectiveness of Fluvital 5%?

Official guidance notes that consuming alcohol while taking Fluvital 5% may enhance certain central nervous system (CNS) effects. Patients are typically advised to follow their usual diet unless a healthcare provider provides specific instructions regarding dietary intake.


Q: What should I look out for that indicates a serious side effect from Fluvital 5%?

Symptoms of rare but serious systemic toxicity, such as severe abdominal pain, bloody diarrhea, vomiting, fever, or chills, are considered medical emergencies and require immediate medical attention. These symptoms are more likely in individuals with DPD deficiency.


Q: Why is Fluvital 5% only available by prescription?

Fluvital 5% is classified as prescription-only (Rx) due to its potent mechanism of action and the necessary medical supervision required for safe use. This is primarily to ensure appropriate patient selection and to monitor for the risk of severe systemic toxicity, particularly in patients who may have DPD enzyme deficiency.


Q: Can Fluvital 5% be used on sensitive skin areas?

Official labeling warns that the medication is highly irritating and must not be used in or around the eyes, eyelids, nostrils, lips, or other mucous membranes. For application on sensitive skin areas, it is important to first discuss this with a healthcare provider, as increased irritation is likely in these areas.


Q: Is Fluvital 5% the same as Fluvital 2.5%?

Fluvital 5% contains the same active ingredient, Fluorouracil, but at a higher concentration than the 2.5% strength. The selection of the appropriate strength is a decision made by a healthcare provider based on the individual's condition.


Q: Can you use makeup or other products over Fluvital 5%?

It is generally advised not to apply other creams, lotions, cosmetics, or topical medicines, including makeup, over the treated skin area. Doing so could potentially lead to increased skin irritation or alter the absorption of the medication.


Q: Is it normal to feel a slight burning sensation after applying Fluvital 5%?

Yes, a burning sensation is officially listed as a Very Common or Common side effect in the safety information. This local reaction is often considered an expected sign that the medication is working on the targeted skin cells.


Q: Are there any long-term side effects associated with using Fluvital 5%?

Official documentation focuses on local reactions (such as redness, crusting, and scaling) that are typically expected to resolve within one to two months after treatment is stopped. Rare reports of persistent changes, such as altered skin pigmentation (darkening) or scarring, are associated with severe local skin reactions.


Q: Does sun exposure make Fluvital 5% less effective?

The skin becomes highly sensitive to sunlight (photosensitive) during and immediately after treatment with Fluvital 5%. Regulatory information indicates that sun exposure should be limited because it can significantly increase the intensity of the local skin reaction at the application site.


Q: How often can Fluvital 5% be applied each day?

The standard frequency for approved indications is typically a thin layer applied twice daily. Patients should follow the specific dosing schedule and instructions provided by their healthcare provider.


Q: What is the maximum duration people usually use Fluvital 5% for?

Treatment duration is individualized and determined by the clinical response. For actinic keratoses, the typical course lasts 2 to 4 weeks, while treatment for superficial basal cell carcinoma may require up to 12 continuous weeks of use.


Q: Are skin changes like lightening or darkening common with Fluvital 5%?

The most common and expected reaction is redness (erythema). While rare, pigment changes such as hyperpigmentation (darkening) or scarring have been documented, usually following a severe local inflammatory reaction.


Q: Can Fluvital 5% be used on large areas of the body?

The official prescribing information indicates that the total area of skin being treated at any one time should not exceed 500 cm^2 (about the size of two adult hands). If the affected area is larger than this, it must be treated in sections.


Q: Does taking certain vitamins or supplements affect Fluvital 5%?

Official warnings specifically list the herbal product St. John's Wort as a supplement that can interact with the medication, potentially decreasing its effectiveness. Patients are advised to inform their healthcare provider of all supplements, vitamins, and herbal products they are taking.


Q: Why do doctors prefer Fluvital 5% over oral medications for certain conditions?

Fluvital 5% is a topical product that provides a highly localized therapeutic action directly to the skin's surface. This approach minimizes the amount of medication absorbed systemically into the body compared to oral forms, which helps to focus the treatment and reduce the risk of widespread systemic side effects.


Q: Can Fluvital 5% cause allergic reactions?

Yes, Fluvital 5% is contraindicated in patients with a history of hypersensitivity or documented allergy to its components. Although rare, serious allergic reactions are possible, and patients should monitor for signs of a severe reaction.


Q: What does Fluvital 5% feel like when it's applied?

The most commonly reported local effects after application are a burning sensation, pain, and irritation at the application site. These sensations are often an expected part of the treatment process, signaling that the medicine is actively working.


Q: Do storage conditions matter for Fluvital 5%?

Yes, storage conditions are important for maintaining the drug's effectiveness and safety. Fluvital 5% must be kept in its original container, tightly closed, at a controlled room temperature (e.g., between 20 C and 25 C), and must not be frozen.


Q: Is it true that Fluvital 5% can help with multiple skin issues?

Official regulatory indications for Fluvital 5% include the targeted treatment of both Actinic Keratosis (AK) and Superficial Basal Cell Carcinoma (sBCC).


Q: Has Fluvital 5% been recently approved or is it an older medicine?

The active ingredient, Fluorouracil, is a well-established antimetabolite that has been clinically recognized and utilized for several decades. Various topical formulations have a long history of regulatory approval.


Q: Can I use Fluvital 5% if I have a history of eczema?

The official label warns that applying the medication to inflamed or ulcerated skin may increase systemic absorption. Patients with inflammatory skin conditions such as eczema are generally advised to discuss use with their healthcare provider.


Q: What ingredients should I avoid in cleansers while using Fluvital 5%?

The instructions advise cleansing the area before each application. While no specific non-drug cleanser ingredients are officially prohibited, it is generally recommended to avoid harsh or abrasive products to minimize potential irritation during the treatment period.


Q: Are there studies on Fluvital 5%'s effectiveness in different skin types?

Official research and clinical trials for Fluvital 5% focused primarily on evaluating the effectiveness of lesion clearance in adult patients with AK or sBCC, who were the key populations studied for regulatory approval.


Q: What makes Fluvital 5% different from a regular moisturizer?

Fluvital 5% is a prescription-strength medication classified as an antimetabolite, which actively works by interfering with the metabolic and growth processes of abnormal, rapidly dividing skin cells. This is fundamentally different from a regular moisturizer, which is designed only to hydrate and protect the skin.


Q: Can I use other topical prescriptions while using Fluvital 5%?

Official usage instructions advise patients not to apply any other topical medications to the treated area unless specifically directed to do so by a healthcare provider. Combining topical products could potentially increase local irritation or alter the absorption of the drug.


Q: Is there a specific time of day best for applying Fluvital 5%?

The standard frequency for this medication is generally twice daily. While the official labeling does not specify the exact time, a common practice for a twice-daily regimen is application in the morning and at night.


Q: What percentage of people see an improvement using Fluvital 5%?

Clinical trial evidence reports high rates of lesion clearance, with some studies showing cure rates greater than 90% for specific conditions like actinic keratosis. These reported outcomes support the medication's approved use.


Q: Can I use Fluvital 5% if I am breastfeeding (general question)?

No, official regulatory guidance states that breastfeeding is not recommended during treatment. This is due to the potential for systemic absorption of the active ingredient and the associated risk of serious adverse reactions in the nursing infant.


Q: Are there any dietary restrictions needed while using Fluvital 5%?

Aside from the specific advice regarding alcohol consumption and interaction warnings with supplements like St. John's Wort, patients should typically continue their normal diet unless otherwise instructed by their healthcare provider.


Q: What are the common misuses of Fluvital 5% that people should avoid?

Official warnings emphasize avoiding several common misuses, including applying the drug to broken or inflamed skin, using it near the eyes or mouth, applying it more often than prescribed, or using it under an occlusive dressing (bandage) unless directed by a doctor.

How should Fluvital 5% be stored and disposed of?

Storage Requirements

Fluvital 5% (Topical Fluorouracil) must be stored at controlled room temperature, typically between 20 C and 25 C (68 F to 77 F). It is essential to not freeze the medication, as this can affect the formulation. The product must be kept in its original container, which should be tightly closed to protect it from excessive heat and moisture. A critical safety requirement is to store the medicine out of the sight and reach of children at all times.

Disposal Instructions

Any unused, expired, or leftover Fluvital 5% must be disposed of according to local and national regulatory guidelines for pharmaceutical waste. The medication should not be flushed down a toilet or poured down a drain. Use authorized drug take-back programs when available. If the container has been opened, the remainder of the product must be discarded after the official in-use stability period (e.g., 90 days).

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fluvital 5% found in:

A-Z Index: